Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3262501000168117 | lanadelumab (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3262511000168119 | lanadelumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lanadelumab | Is a | medicinal product | true | Inferred relationship | Some | ||
| lanadelumab | has intended active ingredient | lanadelumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| lanadelumab 300 mg/2 mL injection, vial | Is a | True | lanadelumab | Inferred relationship | Some | |
| lanadelumab 300 mg/2 mL injection, syringe | Is a | True | lanadelumab | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Medicinal product reference set
FHIR